The original cell which gives rise to the "spindle cells" of Kaposi's sarcoma lesions has long been a point of controversy The abnormalities of pulmonary function tests observed in patients with pulmonary Kaposi's sarcoma are usually non-specific and consist of a reduction in the forced expiratory volume in one second/forced vital capacity and a low diffusing capacity (TLCO); although less frequent, a decrease in vital capacity has also been reported.718 22 29 44 The severity of the airways obstruction has been correlated to the widespread finding ofradiological abnormalities and endobronchial Kaposi's sarcoma lesions.22 29 Finally, it has also been suggested that a normal TLCO and an improvement in the alveolararterial oxygen gradient during exercise were more likely to be found in patients with pulmonary Kaposi's sarcoma than in those with opportunistic pneumonia.244 ISOTOPE TESTS Unlike pulmonary infections or lymphoid processes in HIV-infected patients, pulmonary Kaposi's sarcoma does not fix gallium so, in an AIDS patient with or without cutaneous Kaposi's sarcoma, interstitial and/or nodular changes on the chest radiograph that do not label with gallium strongly suggest pulmonary Kaposi's sarcoma. On the other hand, the presence of focal gallium uptake in lungs or mediastinal lymph nodes in patients with Kaposi's sarcoma is highly suggestive of concomitant infection and/or lymphoma. In addition, Kaposi's sarcoma, but not infectious lesions, has been shown to fix thallium,48 other radionuclides such as technetium pertechnetate-99 and pooled human immunoglobulin labelled with indium-ill have also been studied. 4549 The clinical interest of these tests, however, requires further investigation.
MAGNETIC RESONANCE IMAGING
In a recent study, spin echo TI enhancement after gadolinium associated with a marked reduction of the second echo of the spin-echo T2 in the pathological areas were observed in patients with pulmonary Kaposi's sarcoma but not in patients with Pneumocystis carinii pneumonia.50 The angiomatous and fibrous components of Kaposi's sarcoma would account for this finding.
Diagnostic approaches to intrathoracic Kaposi's sarcoma (figure) Whatever their suggestive diagnostic value, no clinical or radiological data allow the clinician to make a firm diagnosis of intrathoracic Kaposi's sarcoma. In most cases fibreoptic bronchoscopy showing suggestive lesions suffices for this diagnosis. In the absence of such lesions thoracoscopy, mediastinoscopy, or thoracotomy are needed, depending on the radiological appearances of the intrathoracic involvement.
DIAGNOSTIC APPROACH IN ASYMPTOMATIC PATIENTS
In patients with known cutaneous Kaposi's sarcoma but without pulmonary symptoms, systematic chest radiography may reveal abnormalities. From the therapeutic point ofview the requirement is not to diagnose Kaposi's sarcoma but to identify infection. In cases where non-invasive investigations such as CT scans, gallium scans, pulmonary function tests, and plasma levels of lactate dehydrogenase (LDH) are all in agreement with a diagnosis of Kaposi's sarcoma, fibreoptic bronchoscopy must be the next step. Either endobronchial Kaposi's sarcoma lesions are seen and the diagnosis is complete, or further radiological and endoscopic examinations must be repeated regularly unless cytotoxic treatment is given for respiratory symptoms. The appearance ofendobronchial Kaposi's sarcoma lesions will confirm retrospectively the diagnosis in most 
